|
PPIP5K1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.061700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.933900E-02 |
| Normal-vs-Stage2 |
2.868600E-01 |
| Normal-vs-Stage3 |
3.816400E-01 |
| Normal-vs-Stage4 |
1.473360E-01 |
| Stage1-vs-Stage2 |
8.639400E-01 |
| Stage1-vs-Stage3 |
3.349900E-02 |
| Stage1-vs-Stage4 |
9.420400E-02 |
| Stage2-vs-Stage3 |
1.333580E-01 |
| Stage2-vs-Stage4 |
8.287700E-02 |
| Stage3-vs-Stage4 |
8.267400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.428610E-01 |
| Normal-vs-AfricanAmerican |
1.259950E-01 |
| Normal-vs-Asian |
4.551700E-02 |
| Caucasian-vs-AfricanAmerican |
5.562600E-01 |
| Caucasian-vs-Asian |
4.561400E-01 |
| AfricanAmerican-vs-Asian |
6.266400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.689610E-01 |
| Normal-vs-Female |
2.100400E-02 |
| Male-vs-Female |
1.363220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.429600E-01 |
| Normal-vs-Extreme_Weight |
4.594400E-01 |
| Normal-vs-Obese |
2.826800E-01 |
| Normal-vs-Extreme_Obese |
2.417600E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.821000E-01 |
| Normal_Weight-vs-Obese |
6.367600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.765200E-01 |
| Extreme_Weight-vs-Obese |
7.019600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.473800E-01 |
| Obese-vs-Extreme_Obese |
7.029400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.673800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.726000E-02 |
| Normal-vs-Age(61-80Yrs) |
1.172550E-01 |
| Normal-vs-Age(81-100Yrs) |
4.706100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.043200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.913200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.717900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.130800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.366000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.622400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.781300E-03 |
| Normal-VS-Type2 PRCC |
4.131800E-01 |
| Normal-VS-KIRP CIMP |
8.405900E-02 |
| Normal-VS-Unclassified PRCC |
1.575570E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.431600E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.390200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.362400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.675800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.826000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.013190E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.328400E-01 |
| Normal-vs-N1 |
1.481860E-03 |
| Normal-vs-N2 |
2.066400E-01 |
| N0-vs-N1 |
1.788280E-02 |
| N0-vs-N2 |
4.760800E-01 |
| N1-vs-N2 |
6.328000E-01 |
|
|
